PRME Prime Medicine, Inc. logo

PRME Prime Medicine, Inc.

Healthcare
$2.97+0.68%ClosedMarket Cap: $536.4M

As of 2026-05-25

Institutional Ownership Summary

Investors Holding

187

13F Shares

96,974,039

Ownership %

60.4%

New Positions

43

Increased Positions

109

Closed Positions

28

Reduced Positions

41

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
ARKGARK Genomic Revolution ETF4,729,3161.64%
BBCVirtus Biotech Clinical Trials ETF66,5080.64%
GNOMGlobal X - Genomics & Biotechnology ETF40,6710.27%
XBI3,979,9930.18%
LABUDirexion Daily S&P Biotech Bull 3X ETF202,8350.15%
VFMO502,5730.14%
IDNAiShares Genomics Immunology and Healthcare ETF51,4400.11%
IJE258,9400.07%
IWCiShares Micro-Cap ETF258,9400.07%
IBBQInvesco Nasdaq Biotechnology ETF10,6160.05%
GINNGoldman Sachs Innovate Equity ETF26,7790.04%
VTWV72,4570.03%
IBBiShares Biotechnology ETF704,0920.03%
NAJ881,0620.02%
IWNiShares Russell 2000 Value ETF881,0620.02%
VTWO494,2790.01%
RSSLGlobal X - Russell 2000 ETF45,4320.01%
ISCGiShares Morningstar Small-Cap Growth ETF24,3530.01%
HKJ24,3530.01%
NJM2,534,5850.01%